ENTITY

Mirxes Holding (MIRXES HK)

3
Analysis
Health CareSingapore
MiRXES Pte. Ltd. operates as a biotechnology company. The Company focuses on developing non-invasive screening tests for early detection of cancers, as well as RNA technology for cardiovascular, metabolic, and infectious diseases. MiRXES serves customers worldwide.
more
bearishMirxes Holding
24 Aug 2023 15:58

Mirxes Pre-IPO: Early Signs of Commercialization Challenges

We look at fundamentals of Mirxes, including its key products, commercialization and shareholders, as it is planning to list in Hong Kong.

Logo
588 Views
Share
bearishMirxes Holding
17 Aug 2023 08:55

Pre-IPO Mirxes Holding Company - The Profit Model in the Post Pandemic Era Needs to Be Verified

After the dividend period of COVID, the deterioration of Mirxes's financial position may not be easily reversed, with survival pressure. Challenges...

Logo
335 Views
Share
bullishMirxes Holding
03 Aug 2023 15:00Syndicated

Mirxes Lands US$50M to Take Its Cancer Early Detection Solutions to New Markets

Mirxes will use the capital to scale the adoption and penetration of its stomach cancer blood test, GASTROClear, in major APAC markets

Logo
e27
281 Views
Share
No more insights
x